| ATC code C: Cardiovascular system |
|---|
|
| Other ATC codes |
ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) |
|
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
| Bufadienolides |
| ||||||
|---|---|---|---|---|---|---|---|
| Cardenolides |
| ||||||
| |||||||
| Channel blockers |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receptor agonists and antagonists |
| ||||||||||||
| Ion transporters |
| ||||||||||||
| |||||||||||||
| Sympathomimetics |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PDE3 inhibitors | |||||||||||||||
| Calcium sensitizers | |||||||||||||||
| Others | |||||||||||||||
| |||||||||||||||
| Nitrovasodilators | |
|---|---|
| Quinolone vasodilators | |
| Others | |
| |
| Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
|---|---|---|---|---|---|
| Other antagonists |
| ||||
| |||||
| Nitrovasodilator (arterioles and venules) | |
|---|---|
| Hydrazinophthalazines (arterioles) | |
| Potassium channel openers (arterioles) | |
| Calcium channel blockers (arterioles) |
|
| |
| Sulfonamides (and etacrynic acid) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Potassium-sparing (at CD) |
| ||||||||
| Osmotic diuretics (PT, DL) | |||||||||
| Vasopressin receptor inhibitors (DCT and CD) | |||||||||
| Other | |||||||||
| Combination products | |||||||||
| |||||||||
| Phenylethanolamine derivatives | |
|---|---|
| Alpha blockers |
|
| Nicotinic acid and derivatives | |
| Purine derivatives | |
| Ergot alkaloids | |
| Other peripheral vasodilators | |
| Antihemorrhoidals for topical use |
| ||||||
|---|---|---|---|---|---|---|---|
| Antivaricose therapy |
| ||||||
| Capillary stabilising agents |
| ||||||
| β, non-selective | |
|---|---|
| β1-selective | |
| β2-selective | |
| α1- + β-selective | |
| |
| Calcium |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Potassium |
| ||||||||||||||||||||||||
| Sodium |
| ||||||||||||||||||||||||
| Chloride |
| ||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||
| ACE inhibitors ("-pril") |
|
|---|---|
| AIIRAs ("-sartan") |
|
| Renin inhibitors ("-kiren") | |
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| Other | |
| |
| GI tract |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liver |
| ||||||||||||
| Blood vessels |
| ||||||||||||
| Combinations | |||||||||||||
| Other | |||||||||||||
| |||||||||||||